Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31.

A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?

Author information

  • 1Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol Q4076, Australia.

Abstract

CONTEXT:

Despite improvements in mental health services in recent decades, it is unclear whether the risk of mortality in schizophrenia has changed over time.

OBJECTIVE:

To explore the distribution of standardized mortality ratios (SMRs) for people with schizophrenia.

DATA SOURCES:

Broad search terms were used in MEDLINE, PsychINFO, Web of Science, and Google Scholar to identify all studies that investigated mortality in schizophrenia, published between January 1, 1980, and January 31, 2006. References were also identified from review articles, reference lists, and communication with authors.

STUDY SELECTION:

Population-based studies that reported primary data on deaths in people with schizophrenia.

DATA EXTRACTION:

Operationalized criteria were used to extract key study features and mortality data.

DATA SYNTHESIS:

We examined the distribution of SMRs and pooled selected estimates using random-effects meta-analysis. We identified 37 articles drawn from 25 different nations. The median SMR for all persons for all-cause mortality was 2.58 (10%-90% quantile, 1.18-5.76), with a corresponding random-effects pooled SMR of 2.50 (95% confidence interval, 2.18-2.43). No sex difference was detected. Suicide was associated with the highest SMR (12.86); however, most of the major causes-of-death categories were found to be elevated in people with schizophrenia. The SMRs for all-cause mortality have increased during recent decades (P = .03).

CONCLUSIONS:

With respect to mortality, a substantial gap exists between the health of people with schizophrenia and the general community. This differential mortality gap has worsened in recent decades. In light of the potential for second-generation antipsychotic medications to further adversely influence mortality rates in the decades to come, optimizing the general health of people with schizophrenia warrants urgent attention.

PMID:
17909124
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk